from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0631c/recC

LFCtreatmentdescriptionclass of inhibitor

-0.475

Amikacinug/mL Amikacintranslation

-0.305

Cap5-10ug/mL Capreomycintranslation

-0.814

Rox10-50 ug/mL Roxithromycintranslation

-0.389

SM2-5 ug/mL Streptomycintranslation

-0.981

Tet5-10 ug/mL Tetracyclinetranslation

-0.414

Rif0.2-5ug/mL Rifampicintranscription

-0.027

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.647

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.210

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.083

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.590

Clofazimine10-13 ug/mL Clofaziminerespiration

0.632

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.322

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.971

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.256

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.097

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.348

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.288

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.370

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.268

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.457

KCN5-20 ug/mL Potassium cyaniderespiration

0.330

NaN30.2-2 mM Sodium aziderespiration

-0.258

Nigericin50 uM Nigericinrespiration

-1.131

TRC10-150 ug/mL Triclosanrespiration

-0.336

TRZ10-25 ug/mL Thioridazinerespiration

-0.680

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.925

menadione6-10 ug/mL Menadionerespiration

-0.392

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.432

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.078

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.415

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.693

NRP_1Non-replicating persistence stage 1dosRassociated

0.093

Amp0.2mg/mL AmpicillincellWall

0.546

Cephalexin20-100 ug/mL CephalexincellWall

0.458

Cerulenin0.32-5 ug/mL CerulenincellWall

0.249

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.263

EMB10-20 ug/mL EthambutolcellWall

0.220

Eta12-40 ug/mL EthionamidecellWall

0.673

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.101

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.832

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.892

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.799

BZA0.12 mg/mL BenzamidearomaticAmides

-0.363

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.218

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.840

H2O24 mM hydrogen peroxideDNAdamaging

0.784

Levo10 ug/mL LevofloxacinDNAdamaging

-0.210

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.691

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.856

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.092

UVUV-irradiationDNAdamaging

1.413

ARP41-4 ug/mL Antitubercular compound ARP4?

0.481

Antimycin12.5-50 ug/mL Antimycin A?

0.874

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.405

PA_110-50 ug/mL Antitubercular compound PA-1?

0.253

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.097

PA8240.2-2 ug/mL PA-824?

-0.837

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.318

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.226

mercaptoethanol2 mM 2-Mercaptoethanol?

0.716

methoxatin10-20 ug/mL Methoxatin?